TORONTO, July 2 /PRNewswire/ --

Euoko Inc. (OTC Bulletin Board: EUKO) entered into a binding letter
agreement on April 5, 2007 to acquire all issued and outstanding shares of
Euoko Inc. (Canada), a private company which announced today the major
release of 24 new scientifically-advanced luxury skin treatments formulated
as alternatives to clinical laser procedures and cosmetic injections. This
comprehensive product collection addresses such skin concerns as wrinkles,
fine lines, dull skin tones, blemishes and oxidation, and promises to restore
a youthful, radiant appearance to all skin types.

"The advanced skin care market is at a key point in its lucrative
development. Increasing consumer demand for effective products that deliver
visible results coincides with advances in biotechnology, biology,
nanotechnology and peptide technology that can deliver such results for the
first time in the history of this industry," said Brandon Truaxe, President
and CEO of Euoko Inc. (Canada). "This addition to our portfolio represents
more than three years of research and solid effort of a talented team that is
most excited about delivering these advances in avant-garde formulations that
define new standards in this category."

Euoko Inc. (Canada) has published detailed information about these
products on its website at http://www.euoko.com. These products are also
available for purchase on the aforementioned multilingual, multicurrency
website.

Dr. Adel Rammal, Director of Scientific Affairs of Euoko Inc. (Canada)
said, "These products combine the highest concentrations of the most unique,
most effective active ingredients sourced from across the world with a
powerful, proprietary delivery system into stable, clean, pleasant
formulations."

The new product portfolio spans five treatment collections:

R-Series restores a bright, energetic glow to the skin's appearance,
representing an imperative arsenal for battling dull skin tones common in
today's stressful, busy lifestyles.

W-Series promises to deliver a flawless, white, even skin tone, targeting
overall skin lightening and such spot darkness as freckles, age spots and sun
spots, without the use of hydroquinone or kojic acid - two commonly-used
agents with a history of safety concerns.

Y-Series uses the latest advances in active technology, including
peptides, fermentation-based derivatives, marine compounds and
biotechnologically-obtained molecules to lessen the appearance of fine line
and wrinkles. These active principles feature peptides with effects similar
to those of injection-based treatments and laser procedures, including a
tri-peptide that mimics the activity of a protein found in the venom of the
temple viper, as well as okra oligopeptides.

A-Series features a proprietary blend of fruit acids, antibacterial
ogliopeptides, vitamins and other clinical actives, as well as multiple
sesame and marine-based sebum-regulating agents, to deliver blemish-free skin
with unprecedented efficacy.

P-Series incorporates the finest peptides, marine derivatives, metabolic
enhancers, DNA protectors, as well as antioxidants, to offer maximum skin
protection from oxy-radicals, carbonyl-radicals, pollution, UV and visible
light. This collection replenishes lost nutrients and creates a perfectly
clean, moist environment in which the skin's repair mechanisms can function
optimally.

Clarification Note: As Euoko Inc. (USA) will cease all of its current
operations before the completion of the impending acquisition of Euoko Inc.
(Canada), it must be noted that this press release issued by Euoko Inc. (USA)
may reflect the activities of Euoko Inc. (Canada) and the opinions of the
management of Euoko Inc. (Canada). The text of the binding letter agreement
for Euoko Inc. (USA) to acquire all issued and outstanding shares of the
private entity, Euoko Inc. (Canada) from its private shareholders can be
accessed by visiting the website address,
http://sec.edgar-online.com/2007/04/25/0001085037-07-000921/Section11.asp.

About Euoko Inc. (USA) (OTC Bulletin Board: EUKO):

Euoko Inc. (USA) was in the business of manufacturing custom pieces of
jewellery on a piece-by-piece basis for its customers. On April 5, 2007, the
company entered into a binding agreement to purchase all of the issued and
outstanding shares of Euoko Inc. (Canada), a private company whose primary
business is the development, marketing and distribution of luxury skin
treatments. The company adopted its present name on May 24, 2007 to reflect
that the activity of Euoko Inc. (Canada) will represent the sole activity
Euoko Inc. (USA) upon closure of the impending acquisition. The Company has
discontinued its jewellery operation since entering into the aforementioned
merger agreement to acquire Euoko Inc. (Canada). For further information
about Euoko Inc. (USA), please contact Dwight Webb at +1-604-684-6412.

About Euoko Inc. (Canada) (www.euoko.com):

Euoko Inc. (Canada) is an emerging luxury brand that develops, markets
and distributes scientifically-advanced skin treatments. Its current
portfolio spans five treatment collections that target aging, dull skin
tones, skin protection, uneven pigmentation and blemishes. This product line
offers comprehensive solutions to such skin concerns as wrinkles, fine lines,
under-eye dark circles, dark spots, cellulite, acne, oxidation, environmental
exposure and skin fatigue. Combined with innovative products for basic daily
cleansing and facial priming, this product portfolio offers a complete line
of synergistic formulations that target the most demanding luxury consumer.
The company's well-appointed, understated primary and secondary packaging
communicates innovation, science and sophistication, while reflecting the
prestige positioning of the portfolio. The company sells its product line
through varied distribution channels in select North American, European and
Middle Eastern markets, as well as globally through its internally-operated,
multicurrency, multilingual website (www.euoko.com). For further information
about Euoko Inc. (Canada), please contact Carmela Tassone at +1-858-366-4250
x 103.

Safe Harbour for Forward-Looking and Cautionary Statements

Statements in this press release regarding Euoko Inc., the benefits of
its products and all other statements in this release other than the
recitation of historical facts are forward-looking statements. These
statements involve a number of risks, uncertainties and other factors that
could cause actual results, performance or achievements of Euoko Inc. to be
materially different from any future results, performance or achievements
expressed or implied by these forward-looking statements. Factors that might
cause such a difference include: increased competitive pressure from other
industry participants, the inability to execute any element of Euoko Inc.'s
business strategy, including the retention of customers; selling additional
products to existing and new customers; and success in expanding our customer
base and product offerings. Forward-looking statements included herein speak
only as of the date hereof and we disclaim any obligation to revise or update
such statements to reflect events or circumstances after the date hereof or
to reflect the occurrence of unanticipated events or circumstances.

Web site: http://www.euoko.com